SkylightFrom Dec 17 NR
"Quinsam would like to remind investors that it invested in $150,000 of units of CBII Insights in September 2020. The company has since changed its name to Skylight Health. We acquired 1,000,000 units of the company at $0.15 per unit, which included a half warrant at $0.20. The units remain subject to a statutory hold until January 24, 2021. Skylight shares recently traded at $1.20."
Currently trading at $ 1.34
1.5 million shares (with warrant exercise) at average cost of $0.166
Implied profit (assuming all shares were or could be sold today) $ 1.76M!!
(1.5m x (1.34-.166))